The association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept. [electronic resource]
Producer: 20180427ISSN:- 1098-2825
- Adolescent
- Adult
- Cohort Studies
- Etanercept -- therapeutic use
- Female
- Humans
- Immunosuppressive Agents -- therapeutic use
- Linkage Disequilibrium
- Male
- Middle Aged
- NLR Family, Pyrin Domain-Containing 3 Protein -- genetics
- Polymorphism, Single Nucleotide -- genetics
- Receptors, Tumor Necrosis Factor, Type I -- genetics
- Spondylitis, Ankylosing -- drug therapy
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.